Corcept Therapeutics Earnings Estimate

CORT Stock

USD 50.86 0.89 1.78%

The next projected EPS of Corcept Therapeutics is estimated to be 0.3375 with future projections ranging from a low of 0.325 to a high of 0.36. Corcept Therapeutics' most recent 12-month trailing earnings per share (EPS TTM) is at 1.26. Please be aware that the consensus of earnings estimates for Corcept Therapeutics Incorporated is based on EPS before non-recurring items and includes expenses related to employee stock options.

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Corcept Therapeutics is projected to generate 0.3375 in earnings per share on the 31st of December 2024. Corcept Therapeutics earnings estimates show analyst consensus about projected Corcept Therapeutics Incorporated EPS (Earning Per Share). It derives the highest and the lowest estimates based on Corcept Therapeutics' historical volatility. Many public companies, such as Corcept Therapeutics, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm. By analyzing Corcept Therapeutics' earnings estimates, investors can diagnose different trends across Corcept Therapeutics' analyst sentiment over time as well as compare current estimates against different timeframes. At this time, Corcept Therapeutics' Gross Profit is comparatively stable compared to the past year. Pretax Profit Margin is likely to gain to 0.24 in 2025, whereas Gross Profit Margin is likely to drop 0.78 in 2025.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Corcept Therapeutics Incorporated. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

Corcept Therapeutics Earnings Estimation Breakdown

The calculation of Corcept Therapeutics' earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Corcept Therapeutics is estimated to be 0.3375 with the future projection ranging from a low of 0.325 to a high of 0.36. Please be aware that this consensus of annual earnings estimates for Corcept Therapeutics Incorporated is based on EPS before non-recurring items and includes expenses related to employee stock options.

Last Reported EPS

0.41

0.33

Lowest

Expected EPS

0.3375

0.36

Highest

Corcept Therapeutics Earnings Projection Consensus

Suppose the current estimates of Corcept Therapeutics' value are higher than the current market price of the Corcept Therapeutics stock. In this case, investors may conclude that Corcept Therapeutics is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Corcept Therapeutics' stock will quickly adjusts to the new information provided by the consensus estimate.

Number of Analysts	Historical Accuracy	Last Reported EPS		Estimated EPS for 31st of December 2024	Current EPS (TTM)
5	73.63%	0.41		0.3375	1.26

Corcept Therapeutics Earnings per Share Projection vs Actual

Actual Earning per Share of Corcept Therapeutics refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Corcept Therapeutics Incorporated predict the company's earnings will be in the future. The higher the earnings per share of Corcept Therapeutics, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.

Corcept Therapeutics Estimated Months Earnings per Share

For an investor who is primarily interested in generating an income out of investing in entities such as Corcept Therapeutics, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Corcept Therapeutics should always be considered in relation to other companies to make a more educated investment decision.

Corcept Quarterly Analyst Estimates and Surprise Metrics

Earnings surprises can significantly impact Corcept Therapeutics' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.

Reported	Fiscal Date	Estimated EPS	Reported EPS	Surprise
2024-10-30	2024-09-30	0.28	0.41	0.13	46
2024-07-29	2024-06-30	0.23	0.32	0.09	39
2024-05-01	2024-03-31	0.22	0.25	0.03	13
2024-02-15	2023-12-31	0.26	0.28	0.02	7
2023-11-01	2023-09-30	0.22	0.28	0.06	27
2023-08-02	2023-06-30	0.15	0.25	0.1	66
2023-05-03	2023-03-31	0.19	0.14	-0.05	26
2023-02-28	2022-12-31	0.23	0.14	-0.09	39
2022-11-03	2022-09-30	0.23	0.3	0.07	30
2022-08-03	2022-06-30	0.24	0.24	0.0	0
2022-05-05	2022-03-31	0.24	0.2	-0.04	16
2022-02-15	2021-12-31	0.22	0.26	0.04	18
2021-11-03	2021-09-30	0.2	0.24	0.04	20
2021-07-29	2021-06-30	0.16	0.21	0.05	31
2021-05-06	2021-03-31	0.21	0.18	-0.03	14
2021-02-23	2020-12-31	0.19	0.2	0.01	5
2020-11-03	2020-09-30	0.21	0.17	-0.04	19
2020-08-04	2020-06-30	0.22	0.23	0.01	4
2020-05-04	2020-03-31	0.22	0.25	0.03	13
2020-02-20	2019-12-31	0.25	0.24	-0.01	4
2019-11-07	2019-09-30	0.2	0.22	0.02	10
2019-08-01	2019-06-30	0.18	0.17	-0.01	5
2019-05-09	2019-03-31	0.19	0.15	-0.04	21
2019-02-25	2018-12-31	0.15	0.18	0.03	20
2018-11-01	2018-09-30	0.17	0.14	-0.03	17
2018-08-09	2018-06-30	0.24	0.2	-0.04	16
2018-05-08	2018-03-31	0.16	0.19	0.03	18
2018-02-22	2017-12-31	0.18	0.17	-0.01	5
2017-11-02	2017-09-30	0.14	0.11	-0.03	21
2017-08-01	2017-06-30	0.07	0.1	0.03	42
2017-05-01	2017-03-31	0.03	0.04	0.01	33
2017-03-06	2016-12-31	0.04	0.04	0.0	0
2016-11-01	2016-09-30	0.01	0.02	0.01	100
2016-08-02	2016-06-30	0.01	0.01	0.0	0
2016-05-03	2016-03-31	0.01	-2.0E-4	-0.0102	102
2016-03-01	2015-12-31	-0.01	0.01	0.02	200
2015-11-05	2015-09-30	-0.02	-0.01	0.01	50
2015-08-05	2015-06-30	-0.04	-0.02	0.02	50
2015-05-07	2015-03-31	-0.04	-0.05	-0.01	25
2015-03-04	2014-12-31	-0.06	-0.04	0.02	33
2014-11-04	2014-09-30	-0.07	-0.06	0.01	14
2014-08-05	2014-06-30	-0.1	-0.07	0.03	30
2014-05-07	2014-03-31	-0.09	-0.14	-0.05	55
2014-03-05	2013-12-31	-0.1	-0.11	-0.01	10
2013-11-07	2013-09-30	-0.12	-0.11	0.01	8
2013-08-08	2013-06-30	-0.11	-0.12	-0.01	9
2013-05-02	2013-03-31	-0.09	-0.11	-0.02	22
2013-03-07	2012-12-31	-0.09	-0.11	-0.02	22
2012-10-31	2012-09-30	-0.08	-0.08	0.0	0
2012-08-07	2012-06-30	-0.11	-0.09	0.02	18
2012-05-03	2012-03-31	-0.11	-0.13	-0.02	18
2012-03-05	2011-12-31	-0.09	-0.12	-0.03	33
2011-11-07	2011-09-30	-0.1	-0.08	0.02	20
2011-08-08	2011-06-30	-0.09	-0.11	-0.02	22
2011-05-04	2011-03-31	-0.1	-0.09	0.01	10
2011-03-09	2010-12-31	-0.1	-0.1	0.0	0
2010-11-10	2010-09-30	-0.1	-0.1	0.0	0
2010-08-12	2010-06-30	-0.09	-0.09	0.0	0
2010-05-11	2010-03-31	-0.08	-0.1	-0.02	25
2010-03-25	2009-12-31	-0.1	-0.09	0.01	10
2009-11-10	2009-09-30	-0.1	-0.09	0.01	10
2009-08-11	2009-06-30	-0.11	-0.1	0.01	9
2009-05-11	2009-03-31	-0.1	-0.11	-0.01	10
2009-03-30	2008-12-31	-0.11	-0.13	-0.02	18
2008-11-13	2008-09-30	-0.12	-0.11	0.01	8
2008-08-13	2008-06-30	-0.1	-0.09	0.01	10
2008-05-12	2008-03-31	-0.15	-0.1	0.05	33
2008-03-27	2007-12-31	-0.1	-0.11	-0.01	10
2007-11-08	2007-09-30	-0.09	-0.09	0.0	0
2007-08-13	2007-06-30	-0.09	-0.04	0.05	55
2007-05-09	2007-03-31	-0.18	-0.1	0.08	44
2007-03-28	2006-12-31	-0.28	-0.16	0.12	42
2006-11-08	2006-09-30	-0.28	-0.28	0.0	0
2006-08-10	2006-06-30	-0.27	-0.35	-0.08	29
2006-05-09	2006-03-31	-0.27	-0.3	-0.03	11
2006-03-08	2005-12-31	-0.25	-0.23	0.02	8
2005-11-08	2005-09-30	-0.24	-0.23	0.01	4
2005-08-09	2005-06-30	-0.3	-0.18	0.12	40
2005-05-11	2005-03-31	-0.28	-0.24	0.04	14
2005-03-03	2004-12-31	-0.29	-0.24	0.05	17
2004-10-28	2004-09-30	-0.25	-0.18	0.07	28
2004-08-09	2004-06-30	-0.19	-0.18	0.01	5

About Corcept Therapeutics Earnings Estimate

The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Corcept Therapeutics earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Corcept Therapeutics estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Corcept Therapeutics fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'

Please read more on our stock advisor page.

	Last Reported	Projected for Next Year
Retained Earnings	462.9 M	486.1 M
Retained Earnings Total Equity	224.2 M	235.4 M
Earnings Yield	0.03	0.03
Price Earnings Ratio	28.52	29.95
Price Earnings To Growth Ratio	3.87	4.06

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Corcept Stock Analysis

When running Corcept Therapeutics' price analysis, check to measure Corcept Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Corcept Therapeutics is operating at the current time. Most of Corcept Therapeutics' value examination focuses on studying past and present price action to predict the probability of Corcept Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Corcept Therapeutics' price. Additionally, you may evaluate how the addition of Corcept Therapeutics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC